Radiation Oncology Institute (ROI) Innovation Awards Grant

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

About ASTRO
Founded in 1958, ASTRO’s mission is to advance the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving health care environment.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. These medical professionals, found at hospitals, cancer treatment centers and academic research facilities around the globe, make up the radiation therapy treatment teams that are critical in the fight against cancer. Together, these teams treat more than one million cancer patients each year. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research and advocacy.
ASTRO provides members with the continuing medical education, health policy analysis, patient information resources and advocacy that they need to succeed in today’s ever-changing health care delivery system.
ROI awards grants to accelerate bold and innovative ideas in radiation therapy. Requests for Proposals (RFPs) are strategically developed to inspire research that is practical and has the potential to transform clinical practice and the care delivered to patients on a daily basis.
ROI is currently accepting applications for the 2026 Innovation Awards through the "Optimizing Combination Radiation Therapy and Immunotherapy" RFP. Recent advances in both radiation therapy and immunotherapy have expanded the possibilities for combining these modalities to more effectively treat cancer and improve outcomes for patients. The 2026 Innovation Awards will support research to better understand how to optimally combine these modalities and the mechanisms for synergy so that more patients can potentially benefit.